STOCK Flt4tm2.1Ali/Oulu

Status

Available to order

EMMA IDEM:09463
International strain nameSTOCK Flt4tm2.1Ali/Oulu
Alternative nameVegfr3flox/flox
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolFlt4tm2.1Ali,
Gene/Transgene symbolFlt4

Information from provider

ProviderKari Alitalo
Provider affiliationTranslational Cancer Biology Program, Wihuri Research Institute, University of Helsinki
Genetic informationVegfr3 conditional mouse
Phenotypic informationHomozygous:
Homozygous mice for this allele are viable and fertile, and do not display any pathological phenotype. When these mutant mice are bred to mice that express Cre recombinase, the resulting offspring will have the first exon and part of the first intron of the Vegfr3 mouse gene deleted in the cre-expressing tissues.

Heterozygous:
Heterozygous mice for this allele are viable and fertile, and do not display any pathological phenotype.
References
  • Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.;Haiko Paula, Makinen Taija, Keskitalo Salla, Taipale Jussi, Karkkainen Marika J, Baldwin Megan E, Stacker Steven A, Achen Marc G, Alitalo Kari, ;2008;Molecular and cellular biology;28;4843-50; 18519586
  • VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.;Tammela Tuomas, Zarkada Georgia, Nurmi Harri, Jakobsson Lars, Heinolainen Krista, Tvorogov Denis, Zheng Wei, Franco Claudio A, Murtomäki Aino, Aranda Evelyn, Miura Naoyuki, Ylä-Herttuala Seppo, Fruttiger Marcus, Mäkinen Taija, Eichmann Anne, Pollard Jeffrey W, Gerhardt Holger, Alitalo Kari, ;2011;Nature cell biology;13;1202-13; 21909098
  • VEGFR3 does not sustain retinal angiogenesis without VEGFR2.;Zarkada Georgia, Heinolainen Krista, Makinen Taija, Kubota Yoshiaki, Alitalo Kari, ;2015;Proceedings of the National Academy of Sciences of the United States of America;112;761-6; 25561555
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Oulu, Oulu, Finland
Animals used for archivingheterozygous C57BL/6, wild-type C57BL/6NCrl
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.;Haiko Paula, Makinen Taija, Keskitalo Salla, Taipale Jussi, Karkkainen Marika J, Baldwin Megan E, Stacker Steven A, Achen Marc G, Alitalo Kari, ;2008;Molecular and cellular biology;28;4843-50; 18519586
  • VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.;Tammela Tuomas, Zarkada Georgia, Nurmi Harri, Jakobsson Lars, Heinolainen Krista, Tvorogov Denis, Zheng Wei, Franco Claudio A, Murtomäki Aino, Aranda Evelyn, Miura Naoyuki, Ylä-Herttuala Seppo, Fruttiger Marcus, Mäkinen Taija, Eichmann Anne, Pollard Jeffrey W, Gerhardt Holger, Alitalo Kari, ;2011;Nature cell biology;13;1202-13; 21909098
  • VEGFR3 does not sustain retinal angiogenesis without VEGFR2.;Zarkada Georgia, Heinolainen Krista, Makinen Taija, Kubota Yoshiaki, Alitalo Kari, ;2015;Proceedings of the National Academy of Sciences of the United States of America;112;761-6; 25561555

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).